Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Thursday 28 February 2019 5:41 pm  |  Updated:  Monday 03 June 2019 1:36 am

UK cannabis firm Jacana blazes a trail to possible London listing

Cannabis firm Jacana is “considering” a stock market flotation this year after raising $20m (£15.08m) in private investment in 2018.

Read more: England lock George Kruis has high hopes for cannabis oil business

Serial entrepreneur Alexandra Chong, the company’s co-founder, said “all options were on the table” in terms of funding, as Jacana seeks to expand its production facility in Jamaica to meet the budding demand for medicinal cannabis in the UK.

In November, the government made it legal to prescribe cannabis to certain patients. Home Secretary Sajid Javid said the move would “benefit the lives of ill patients currently suffering in silence”.

Last year, Jacana got the backing of a roll call of leading investors – among them venture capitalists Eileen Burbidge and Bill Tai alongside former Microsoft executive Mich Mathews.

Chong told City PM: “We're exploring all avenues to help us grow the business, including an initial public offering (IPO), but there is no timeline on that.

“Although legalisation of recreational cannabis may be a way off, we’re positioning ourselves to succeed in that market as well.”

The medicinal cannabis industry is predicted to be worth more than £75bn worldwide by 2024.

Competitor European Cannabis Holdings (ECH) completed its first shipment of marijuana to the UK last week.

ECH is reported to be mulling an IPO of its own, with a potential value of over £100m if it were to take place.

After making her name with the women-only dating app Lulu, which was sold to industry giant Badoo in 2016, Chong said she was focusing on her “passion project” of creating the “champagne of cannabis”.

Chong, who grew up in Jamaica, said she had seen first-hand how cannabis can help overcome “chronic pain, sleep issues, epilepsy, and transform lives” and was “certain” medicinal cannabis would take off in the UK. 

Read more: Marlboro-maker in talks to invest in Canadian cannabis producer Cronos

Jacana has hired more than 50 staff in Jamaica as well as a dozen employees in the UK. 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Microsoft
  • People
  • Sajid Javid

Trending Articles

  • Top Burnham adviser calls for capital gains and inheritance tax hikes

  • Clarkson’s Farm and why businesses must stop blaming the weather

  • Two solicitors linked to Post Office scandal charged with misconduct

  • Lloyd’s deputy chair: The City is a club in the best sense

  • Revealed: Secret Treasury plan to tax State Pension before it is paid out

More from City PM

  • Emily Thornberry has insulted Carnival-goers and Gooners alike

    Opinion
    Emily Thornberry addressing media at press conference, wearing a navy blazer, standing at a podium with microphones
  • James Watt: I want to buy back Brewdog

    Retail
    Brewdog CEO James Watt
  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire
  • Award winning Medtech firm excels again

    Partner
    Unable to generate alt text without specific article content or context. Please provide more details or context.
  • IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy